SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-010647
Filing Date
2024-01-19
Accepted
2024-01-19 06:09:31
Documents
17
Period of Report
2024-01-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d100554d8k.htm   iXBRL 8-K 32283
2 EX-1.1 d100554dex11.htm EX-1.1 182046
3 EX-5.1 d100554dex51.htm EX-5.1 8570
4 EX-99.1 d100554dex991.htm EX-99.1 8942
8 GRAPHIC g100554g0117173553685.jpg GRAPHIC 2458
9 GRAPHIC g100554g86o17.jpg GRAPHIC 4319
  Complete submission text file 0001193125-24-010647.txt   420288

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA alec-20240117.xsd EX-101.SCH 2838
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE alec-20240117_lab.xml EX-101.LAB 17994
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alec-20240117_pre.xml EX-101.PRE 11253
11 EXTRACTED XBRL INSTANCE DOCUMENT d100554d8k_htm.xml XML 3328
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

IRS No.: 822933343 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38792 | Film No.: 24543659
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)